27660548|t|Thymectomy for Myasthenia Gravis: A 10- year Review of Cases at the Hospital Universiti Sains Malaysia
27660548|a|A thymectomy is considered effective for patients with myasthenia gravis (MG). Although a few studies have described the role of a thymectomy in the treatment of MG in Asians countries, there are no published data on the application of this surgical approach for MG in Malaysia. We aimed to describe the clinical outcomes of MG patients who underwent a thymectomy and the factors affecting these outcomes. This was a retrospective study involving 16 patients with MG who underwent a thymectomy at the Hospital Universiti Sains Malaysia (HUSM) from January 2002 until December 2012, with a follow-up period ranging from 3-120 months. The study consisted of 16 patients aged 22-78 years, 10 of whom were males. The overall remission / improvement rate was 87.5%, and the rate of clinical outcomes classified as unchanged / worsened was 12.5%. Thymomamatous or non-thymomamatous MG, histology features, Osserman stage and the duration of follow-up were not significant prognostic factors. Post-operative mortality was 6.2% (1 of 16 patients died of septic shock). A thymectomy seems to be an effective treatment for MG, with low surgical morbidity. Patients with a lower Osserman stage and those with/without thymomas had favourable outcomes.
27660548	0	10	Thymectomy	T061	C0040071
27660548	15	32	Myasthenia Gravis	T047	C0026896
27660548	40	44	year	T079	C0439234
27660548	45	51	Review	T170	C0282443
27660548	55	60	Cases	T169	C0868928
27660548	68	102	Hospital Universiti Sains Malaysia	T093	C1708333
27660548	105	115	thymectomy	T061	C0040071
27660548	130	139	effective	T080	C1704419
27660548	144	152	patients	T101	C0030705
27660548	158	175	myasthenia gravis	T047	C0026896
27660548	177	179	MG	T047	C0026896
27660548	197	204	studies	T062	C2603343
27660548	234	244	thymectomy	T061	C0040071
27660548	252	261	treatment	T169	C0039798
27660548	265	267	MG	T047	C0026896
27660548	271	287	Asians countries	T083	C0454705
27660548	302	316	published data	T078	C1511726
27660548	324	335	application	T058	C0185125
27660548	344	361	surgical approach	T169	C0449446
27660548	366	368	MG	T047	C0026896
27660548	372	380	Malaysia	T083	C0024552
27660548	407	424	clinical outcomes	T033	C0243095
27660548	428	430	MG	T047	C0026896
27660548	431	439	patients	T101	C0030705
27660548	456	466	thymectomy	T061	C0040071
27660548	475	482	factors	T169	C1521761
27660548	483	492	affecting	T169	C0392760
27660548	499	507	outcomes	T169	C1274040
27660548	520	539	retrospective study	T062	C0035363
27660548	553	561	patients	T101	C0030705
27660548	567	569	MG	T047	C0026896
27660548	586	596	thymectomy	T061	C0040071
27660548	604	638	Hospital Universiti Sains Malaysia	T093	C1708333
27660548	640	644	HUSM	T093	C1708333
27660548	651	658	January	T080	C3829466
27660548	670	678	December	T080	C3830550
27660548	692	701	follow-up	T058	C1522577
27660548	702	708	period	T079	C1948053
27660548	728	734	months	T079	C0439231
27660548	740	745	study	T062	C2603343
27660548	762	770	patients	T101	C0030705
27660548	771	775	aged	T032	C0001779
27660548	782	787	years	T079	C0439234
27660548	805	810	males	T032	C0086582
27660548	816	833	overall remission	T033	C0544452
27660548	836	847	improvement	T077	C2986411
27660548	848	852	rate	T081	C1521828
27660548	872	876	rate	T081	C1521828
27660548	880	897	clinical outcomes	T033	C1333602
27660548	912	921	unchanged	T033	C0442739
27660548	924	932	worsened	T033	C1457868
27660548	944	957	Thymomamatous	T191	C0040100
27660548	961	981	non-thymomamatous MG	T047	C0026896
27660548	983	992	histology	T169	C4048239
27660548	993	1001	features	T080	C2348519
27660548	1003	1017	Osserman stage	T047	C0012634
27660548	1026	1034	duration	T079	C0449238
27660548	1038	1047	follow-up	T058	C1522577
27660548	1069	1087	prognostic factors	T201	C1514474
27660548	1089	1103	Post-operative	T079	C0032790
27660548	1104	1113	mortality	T033	C1408811
27660548	1132	1140	patients	T101	C0030705
27660548	1141	1145	died	T040	C0011065
27660548	1149	1161	septic shock	T046	C0036983
27660548	1166	1176	thymectomy	T061	C0040071
27660548	1192	1211	effective treatment	T169	C0039798
27660548	1216	1218	MG	T047	C0026896
27660548	1229	1237	surgical	T061	C0543467
27660548	1238	1247	morbidity	T081	C0026538
27660548	1249	1257	Patients	T101	C0030705
27660548	1271	1285	Osserman stage	T047	C0012634
27660548	1309	1317	thymomas	T191	C0040100
27660548	1322	1341	favourable outcomes	T169	C1274040